Abstract
Recovery from addiction is a complex and dynamic process, with considerable variations across individuals. Despite historical and recent surge of interest in recovery among many stakeholders in the addiction field, empirical research on recovery has been limited. The varying definitions of recovery across different stakeholder groups best illustrate the wide-ranging thinking on recovery, yet how recovery is conceptualized, promoted, and achieved has important implications for how treatment systems should be structured, delivered, and evaluated. The concept of addiction as a chronic illness is redefining the fundamental way we view drug abuse and its treatment. Currently, many efforts are directed toward determining how to provide a continuity of treatment and how to measure if treatment systems are successfully addressing addiction as a chronic disease. In this chapter, we describe empirical patterns of drug use trajectories over the life course, discuss the diverse ways of conceptualizing recovery, and identify key aspects of addiction that require attention as we investigate and treat addiction to promote long-term, stable recovery.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Anglin MD, Hser Y. Treatment of drug abuse. In: Tonry M, Wilson JQ, editors. Drugs and crime, vol. 13. Chicago, IL: University of Chicago Press; 1990. p. 393–460.
Compton WM, Glantz M, Delany P. Addiction as a chronic illness: putting the concept into action. Eval Program Plan. 2003;26:353–4.
Hser Y, Anglin MD, Grella CE, Longshore D, Prendergast ML. Drug treatment careers: a conceptual framework and existing research findings. J Subst Abuse Treat. 1997;14:543–58.
Hser Y, Hoffman V, Grella CE, Anglin MD. A 33-year follow-up of narcotics addicts. Arch Gen Psychiatry. 2001;58:503–8.
Hser Y, Huang D, Chou C, Anglin MD. Trajectories of heroin addiction: growth mixture modeling results based on a 33-year follow-up study. Eval Rev. 2007;31:548–63.
McLellan AT, Lewis DC, O’Brien CP, Kleber HD. Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation. JAMA. 2000;284:1689–95.
Dennis M, Scott C. Managing addiction as a chronic condition. Addict Sci Clin Pract. 2007;4(1):45–55.
Scott CK, Dennis ML. Recovery Management Checkup (RMC) protocol for people with chronic substance use disorders. Bloomington, IL: Chestnut Health Systems; 2002.
Hser Y, Longshore D, Anglin MD. The life course perspective on drug use: a conceptual framework for understanding drug use trajectories. Eval Rev. 2007;31:515–47.
Laudet AB. What does recovery mean to you? lessons from the recovery experience for research and practice. J Subst Abuse Treat. 2007;33:243–56.
White WL. Addiction recovery: its definition and conceptual boundaries. J Subst Abuse Treat. 2007;33:229–41.
Center for Substance Abuse Treatment. National Summit on Recovery: 2005 Conference Report. DHHS Publication No. (SMA) 07-4276. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2007.
Teruya C, Hser YI. Turning points in the life course: current findings and future directions in drug use research. Curr Drug Abuse Rev. 2010; [Epub ahead of print]
Elder Jr GH. Perspectives in the life course. In: Elder GH, editor. Life course dynamics. Ithaca, NY: Cornell University Press; 1985. p. 23–49.
Sampson RJ, Laub JH. Socioeconomic achievements in the life course of disadvantaged men: military service as a turning point, 1940–1965. Am Sociol Rev. 1996;61:347–67.
Laub JH, Sampson RJ. Turning points in the life course: why change matters to the study of crime. Criminology. 1993;31:301–25.
Cloud W, Granfield R. The social process of exiting addiction: a life course perspective. In: Blomqvist J, Koski-Jannes A, Ojesjo L, editors. Addiction and life course. Helsinki, Finland: Nordic Council on Alcohol and Drug Research; 2004. p. 185–202.
Granfield R, Cloud W. Social context and “natural recovery”: the role of social capital in the resolution of drug-associated problems. Subst Use Misuse. 2001;36:1543–70.
Wheaton B, Gotlib IH. Trajectories and turning points over the life course: concepts and themes. In: Gotlib IH, Wheaton B, editors. Stress and adversity over the life course: trajectories and turning points. New York, NY: Cambridge University Press; 1997. p. 1–25.
Hser Y, Huang D, Brecht M, Li L, Evans E. Contrasting trajectories of heroin, cocaine, and methamphetamine use. J Addict Dis. 2008;27:13–21.
Substance Abuse and Mental Health Services Administration. Overview of findings from the 2002 National Survey on Drug Use and Health (Office of Applied Studies, NHSDA Series H-21, DHHS Publication No. SMA 03-3774). Rockville, MD: SAMHSA; 2003.
Center for Human Resource Research. NLSY97 Codebook Supplement Main File Round 8, Prepared for the U.S. Department of Labor, by Center for Human Resource Research. Columbus, OH: The Ohio State University; 2006.
Hser Y, Evans E, Huang D, Brecht M, Li L. Comparing the dynamic course of heroin, cocaine, and methamphetamine use over 10 years. Addict Behav. 2008;33:1581–9.
Nagin DS. Analyzing developmental trajectories: semi-parametric group-based approach. Psychol Methods. 1999;4:39–177.
Nagin DS. Group-based modeling of development. Cambridge, MA: Harvard University Press; 2005.
Muthen B. Latent variable analysis: growth mixture modeling and related techniques for longitudinal data. In: Kaplan D, editor. Handbook of quantitative methodology for the social sciences. Newbury Park, CA: Sage Publications; 2004. p. 345–68.
Muthen B, Asparouhov T. Growth mixture analysis: models with non-Gaussian random effects. In: Fitzmaurice G, Davidian M, Verbeke G, Molenberghs G, editors. Advances in longitudinal data analysis. Boca Raton, FL: Chapman & Hall/CRC Press; 2006.
Chassin L, Presson CC, Pitts SC, Sherman SJ. The natural history of cigarette smoking from adolescence to adulthood in a midwestern community sample: multiple trajectories and their psychosocial correlates. Health Psychol. 2000;19:223–31.
Orlando M, Tucker JS, Ellickson PL, Klein DJ. Developmental trajectories of cigarette smoking and their correlates from early adolescence to young adulthood. J Consult Clin Psychol. 2004;72(3):400–10.
Chassin L, Pitts SC, Prost J. Binge drinking trajectories from adolescence to emerging adulthood in a high-risk sample: predictors and substance abuse outcomes. J Consult Clin Psychol. 2002;70:67–78.
Hix-Small H, Duncan TE, Duncan SC, Okut H. A multivariate associative finite growth mixture modeling approach examining adolescent alcohol and marijuana use. J Psychopathol Behav Assess. 2004;26:255–70.
Ellickson PL, Martino SC, Collins RL. Marijuana use from adolescence to young adulthood: multiple developmental trajectories and their associated outcomes. Health Psychol. 2004;23:299–307.
Anthony JC, Petronis KR. Early-onset drug use and risk of later drug problems. Drug Alcohol Depend. 1995;40:9–15.
Yu J, Williford WR. The age of alcohol onset and alcohol, cigarette, and marijuana use patterns: an analysis of drug use progression of young adults in New York State. Int J Addict. 1992;27:1313–23.
Hser Y. Predicting long-term stable recovery from heroin addiction: findings from a 33-year follow-up study. J Addict Dis. 2007;26:51–60.
The Betty Ford Institute Consensus Panel. What is recovery? A working definition from the Betty Ford Institute. J Subst Abuse Treat. 2007;33:221–8.
World Health Organization (WHO). Basic documents. 35th ed. Geneva, Switzerland: WHO; 1985.
Dennis ML, Foss MA, Scott CK. An eight-year perspective on the relationship between the duration of abstinence and other aspects of recovery. Eval Rev. 2007;31:585–612.
Sobell L, Cunningham JA, Sobell MB. Recovery from alcohol problems with and without treatment: prevalence in two population surveys. Am J Public Health. 1996;7:966–72.
Cross G, Morgan C, Moonye A, Martin C, Rafter J. Alcoholism treatment: a ten-year follow-up study. Alcohol Clin Exp Res. 1990;14:169–73.
Hser Y, Stark ME, Paredes A, Huang D, Anglin MD, Rawson R. A 12-year follow-up of a treated cocaine-dependent sample. J Subst Abuse Treat. 2006;30:219–26.
Scott CK, Foss MA, Dennis ML. Pathways in the relapse–treatment–recovery cycle over 3 years. J Subst Abuse Treat. 2005;28:S63–72.
Weisner C, Ray GT, Mertens JR, Satre DD, Moore C. Short-term alcohol and drug treatment outcomes predict long-term outcome. Drug Alcohol Depend. 2003;1071(3):281–94.
Salome HJ, French MT, Scott C, et al. Investigating the economic costs and benefits of addiction treatment: econometric analysis of the Chicago Target Cities project. Eval Program Plann. 2003;26(3):325–38.
Scott CK, Foss MA, Dennis ML. Factors influencing initial and longer-term responses to substance abuse treatment: a path analysis. Eval Program Plann. 2003;26:287–96.
Laudet A, Savage R, Mahmood D. Pathways to long-term recovery: a preliminary investigation. J Psychoactive Drugs. 2002;34:305–11.
Moos RH, Moos BS. Rates and predictors of relapse after natural and treated remission from alcohol use disorders. Addiction. 2006;101:212–22.
Moos RH. Theory-based processes that promote the remission of substance use disorders. Clin Psychol Rev. 2007;27:537–51.
Vaillant GE. A long-term follow-up of male alcohol abuse. Arch Gen Psychiatry. 1996;53:243–9.
Vaillant G. A 60-year follow-up of alcoholic men. Addiction. 2003;98:1043–51.
Sampson RJ, Laub JH. Life-course desisters? Trajectories of crime among delinquent boys followed to age 70. Criminology. 2003;41:555.
Simpson DD, Sells SB. Opioid addiction and treatment: a 12-year follow-up. Malabar, FL: Krieger; 1990.
Termorshuizen F, Krol A, Prins M, van Ameijden EJ. Long-term outcome of chronic drug use: The Amsterdam Cohort Study among Drug Users. Am J Epidemiol. 2005;161:271–9.
Winick C. Maturing out of narcotic addiction. Bull Narc. 1962;14:1–8.
Anglin MD, Hser Y. Legal coercion and drug abuse treatment: research findings and social policy implications. In: Inciardi J, editor. Handbook of drug control in the United States. Westport, CT: Greenwood Press; 1990. p. 151–76.
Simpson DD, Joe GW, Fletcher BW, Hubbard RL, Anglin MD. A national evaluation of treatment outcomes for cocaine dependence. Arch Gen Psychiatry. 1999;56:507–14.
Simpson DD, Joe GW, Broome KM. A national 5-year follow-up of treatment outcomes for cocaine dependence. Arch Gen Psychiatry. 2002;59:538–44.
Institute of Medicine (IOM). Improving the quality of health care for mental and substance-use conditions. Washington, DC: National Academy Press; 2006.
Rawson, R. Building a treatment system: elements and challenges. Presentation at the Hawaii Addiction Conference/AAPI Workgroup Scientific Conference; May 2009; Honolulu, Hawaii.
McLellan AT, Carise D, Kleber HD. Can the national addiction treatment infrastructure support the public’s demand for quality care? J Subst Abuse Treat. 2003;25:117–21.
Gerstein DR, Harwood HJ. National Academy of Sciences, Institute of Medicine, Division of Health Care Services, Committee for the Substance Abuse Coverage Study, Washington, DC. Treating drug problems, vol. 1: a study of the evolution, effectiveness, and financing of public and private drug treatment systems. Washington, DC: National Academy Press; 1990.
Anglin MD, Hser Y, Grella CE. Drug addiction and treatment careers among clients in the Drug Abuse Treatment Outcome Study (DATOS). Psychol Addict Behav. 1997;11:30823.
Robins JM. Causal inference from complex longitudinal data. In: Berkane M, editor. Latent variable modeling and applications to causality. Lecture notes in statistics, vol. 120. New York, NY: Springer; 1997. p. 69–117.
Robins JM. Marginal structural models versus structural nested models as tools for causal inference. In: Halloran E, editor. Statistical models in epidemiology. New York, NY: Springer; 1999. p. 95–134.
Robins JM, Hernán MA, Brumback B. Marginal structural models and causal inference in epidemiology. Epidemiology. 2000;11:550–60.
Li L, Evans E, Hser Y. A marginal structural modeling approach to assess the cumulative effect of drug treatment on later drug use abstinence. J Drug Issues. 2010;40(1):221–40.
Hser Y, Huang D, Teruya C, Anglin MD. Diversity of drug abuse treatment utilization patterns and outcomes. Eval Program Plann. 2004;27:309–19.
Khalsa ME, Paredes A, Anglin MD, Potepan P, Potter C. Combinations of treatment modalities and therapeutic outcome for cocaine dependence. In: Tims FM, Leukefeld CG, editors. Cocaine treatment: research and clinical perspectives. Rockville, MD: National Institute on Drug Abuse; 1993. p. 237–59. NIDA Research Monograph 135.
McKay JR. Is there a case for extended interventions for alcohol and drug use disorders? Addiction. 2005;100:1594–610.
McKay JR, Merikle E, Mulvaney FD, Weiss RV, Koppenhaver JM. Factors accounting for cocaine use two years following initiation of continuing care. Addiction. 2001;96:213–25.
Wagner EH, Austin BT, Von Korff M. Organizing care for patients with chronic illness. Milbank Q. 1996;74:511–44.
Rush AJ, Koran LM, Keller MB, et al. The treatment of chronic depression, part I. Study design and rationale for evaluating the comparative efficacy of sertraline and imipramine as acute, crossover, continuation and maintenance phase therapies. J Clin Psychiatry. 1993;59:589–97.
Acknowledgment
This work was supported in part by the UCLA Center for Advancing Longitudinal Drug Abuse Research (CALDAR) under grant P30DA016383 (PI: Hser) from the National Institute on Drug Abuse (NIDA). Dr. Hser is also supported by a NIDA Senior Scientist Award (K05DA017648).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Hser, YI., Anglin, M.D. (2010). Addiction Treatment and Recovery Careers. In: Kelly, J., White, W. (eds) Addiction Recovery Management. Current Clinical Psychiatry. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60327-960-4_2
Download citation
DOI: https://doi.org/10.1007/978-1-60327-960-4_2
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-60327-959-8
Online ISBN: 978-1-60327-960-4
eBook Packages: MedicineMedicine (R0)